Screener
Asset Entities ASST Medical Device — Interest Expense, Long-Term Debt
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseLongTermDebt.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Net operating loss | (258,249) | (3,690) |
| Other income/(expense): | ||
| Other income | 955 | 252 |
| Interest expense on long-term notes payable, at fair value | (40) | — |
| Change in fair value on long-term notes payable, at fair value | (299) | — |
| Gain on extinguishment of debt | 30 | — |
| Transaction costs | — | (5,437) |
| Total other income/(expense) | 646 | (5,185) |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — interest expense, long-term debt?
- Asset Entities (ASST) reported medical device — interest expense, long-term debt of $0 in Q2 2026.
- What does medical device — interest expense, long-term debt mean?
- Reflects the cost of servicing long-term financial obligations specifically allocated to the medical device segment. Monitoring this expense provides insight into the segment's debt burden and its impact on overall operational profitability.
Ask your AI about Asset Entities's medical device — interest expense, long-term debt.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude